top of page

Dr. Chandler Walker moves to final round of IU Idea to Startup Pitch Competition

Dr. Walkers business idea "Cell-based therapy for ALS" was selected for advancing to the IU Idea to Startup Pitch Competition finals. This is an in-person event held on October 13 in Bloomington, Indiana. The winner will receive money for further establishing the startup and resources for helping move the idea forward in clinical production.

NDR congratulates Chandler on the opportunity to discuss Secretome as an ALS treatment in Bloomington and hope his hard work brings him the award. NDR supported his idea and funded important pre-clinical data studies bringing him to this research juncture. We hope he can continue his work to bring a promising therapy to ALS patients in a clinical trial through his company Mesocyte Therapeutics LLC.

12 views0 comments

Recent Posts

See All

Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS. You can read about the trial and follow our progress .

bottom of page